Latest Innovation News

Clarity Pharmaceuticals has initiated its second registrational Phase III AMPLIFY trial for the Cu-SAR-bisPSMA PET imaging agent targeting biochemical recurrence of prostate cancer. The multi-centre study aims to generate critical data supporting FDA approval and could redefine prostate cancer diagnostics.

Dotz Nano Limited has announced a A$1.2 million private placement at a discounted share price, accompanied by options, to bolster working capital and support the commercialisation of its carbon capture technology.

TZ Limited has received a second purchase order from Wesco Anixter on behalf of Microsoft, reinforcing its growing role in global data centre security deployments. The combined orders now total approximately AUD 585,000, highlighting strong momentum in TZ’s expansion across key international markets.

OFX Limited reported a resilient FY25 with steady revenue and strong cash flow, while advancing its New Client Platform and strategic market expansion despite economic headwinds.

Green360 Technologies has successfully produced high-quality metakaolin from its kaolin resources, surpassing industry benchmarks and initiating commercial-scale trials with PERMAcast to validate its low-carbon cement formulations.

Avecho Biotechnology has expanded its pivotal Phase III clinical trial for a CBD insomnia treatment by adding new recruitment sites and partnering with pharmaceutical giant Sandoz to boost patient enrolment and regulatory progress.

American West Metals is launching a comprehensive 2025 exploration campaign at its Storm Copper Project in Nunavut, targeting resource expansion and new discoveries along a 110km copper belt.

Worley Limited has reaffirmed its FY25 financial outlook, targeting low double-digit EBITA growth and margins between 8-8.5%, supported by a robust $9.4 billion bookings pipeline and a strategic operational reorganisation.

Noxopharm Limited has raised nearly $2.5 million by selling its entire stake in Nyrada Inc, providing non-dilutive capital to advance its HERACLES clinical trial and expand its research pipeline.

Brazilian Rare Earths Limited has secured a strategic partnership with SENAI CIMATEC to co-develop a rare earths laboratory and pilot plant in Bahia, Brazil, backed by significant funding and aimed at advancing processing capabilities ahead of production.

LTR Pharma has expanded patient access to its fast-acting erectile dysfunction treatment SPONTAN by partnering with TerryWhite Chemmart’s extensive pharmacy network, marking a significant step in its commercial rollout and regulatory strategy.

TechnologyOne Limited has reported a robust first half for FY25, with annual recurring revenue exceeding $500 million well ahead of schedule and profit before tax climbing 33%. The company’s SaaS+ platform and strategic acquisition of CourseLoop are driving growth and positioning it for ambitious long-term targets.